Colorado News Desk

Blepharitis Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape, Upcoming Therapies, Key Companies, and Market Size By DelveInsight

 Breaking News
  • No posts were found

Blepharitis Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape, Upcoming Therapies, Key Companies, and Market Size By DelveInsight

September 13
20:52 2021
Blepharitis Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape, Upcoming Therapies, Key Companies, and Market Size By DelveInsight
Blepheritis Market
The total Blepharitis market size will include the market size of both potential upcoming therapies as well as current treatment regimens in the 7MM.

DelveInsight’s Blepharitis market report provides a comprehensive understanding of Blepharitis, historical and forecasted epidemiology, and Blepharitis market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan).

Some of the Key Highlights from the Blepharitis Market Report

  • Blepharitis is one of the most common ocular disorders seen in clinical practice and it is more common in females than males. 

  • According to Cursiefen et al study, “Unmet Needs in Ophthalmology: A European Vision Institute-Consensus Roadmap 2019–2025,” Blepharitis accounts for 80 percent of all dry eye disease (DED).

  • The major key players that are evaluating their drug candidates for Blepharitis include Premark Pharma, Tarsus Pharmaceuticals, InSite Vision, Nicox Ophthalmic, AxeroVision, and others.

  • Key emerging Blepharitis therapies include AXR-270, PMP2207, ISV-305 (DexaSite), TP-03, Fluticasone Propionate, and several others.

  • PMP2207, a selective inhibitor of pro-inflammatory mediators, is being developed by Premark Pharma as an ophthalmic ointment to be applied to the eyelid and eyelid margin twice daily.

  • Sun Pharma is working on ISV-305 (DexaSite), an eye drop medication that will deliver the steroid dexamethasone to treat inflammation and pain after cataract surgery.

Request for the Webex demo of the report @ Blepharitis Market Outlook

The Blepharitis market report also covers current treatment practices, emerging drugs, Blepharitis market share of individual therapies, and current and forecasted Blepharitis market Size from 2018 to 2030, segmented by seven major markets.

Blepharitis Overview

Blepharitis is an inflammation of the eyelids that causes them to become red, irritated, and itchy, as well as the formation of dandruff-like scales on the eyelashes. It is a chronic external eye disorder that causes red, burning, and irritated eyes. It does not cause serious eye damage, but it can be extremely uncomfortable. It can be caused by bacteria or a skin condition such as scalp dandruff or rosacea.

Blepharitis Epidemiology Segmentation

The Blepharitis report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:

  • Blepharitis Prevalent Population

  • Blepharitis Type-Specific Prevalent Population

  • Blepharitis Diagnosed and Treatable Cases 

Blepharitis Treatment Landscape

Blepharitis is a chronic (long-term) condition that cannot be cured, but Blepharitis symptoms can be managed with proper eyelid hygiene. The current Blepharitis treatment includes:

  • Warm compresses and eyelid cleansing 

  • Corticosteroids (Zylet)

  • Antibiotics (topical, systemic)

  • Fluoroquinolones (ciprofloxacin, moxifloxacin, gatifloxacin)

Blepharitis Market

The total Blepharitis market size will include the market size of both potential upcoming therapies such as AXR-270, PMP2207, ISV-305, TP-03, and others as well as current treatment regimens in the seven major markets.

Get a detailed analysis of the market @ Blepharitis Treatment Market

Blepharitis Pipeline Therapies and Key Companies 

  • AXR-270: AxeroVision

  • PMP2207: Premark Pharma 

  • ISV-305: Sun Pharma

  • TP-03: Tarsus Pharmaceuticals 

  • Fluticasone Propionate: Nicox Ophthalmics  

Table of Contents

1.

Report Introduction

2.

Blepharitis Market Overview at a Glance

3.

Disease Background and Overview: Blepharitis 

4.

Blepharitis Epidemiology and Patient Population

5.

Blepharitis Treatments & Medical Practices

6.

Blepharitis Emerging Therapies

7.

Blepharitis Market Size

8.

7MM Blepharitis: Country-Wise Market Analysis

9.

Report Methodology

10.

DelveInsight Capabilities

11.

Disclaimer

12.

About DelveInsight

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts

Related Reports

Dry Eye Disease Market

Get a comprehensive analysis of Dry Eye Disease pipeline therapies and key companies such as HanAll Biopharma, Bausch & Lomb Incorporated, Aldeyra Therapeutics, Novaliq, Huons, Allergan, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Sandeep Joshi
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/

Categories